FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1975525509> ?p ?o ?g. }

• W1975525509 endingPage "45" @default.
• W1975525509 startingPage "40" @default.
• W1975525509 abstract "Background Oxaliplatin hypersensitivity (OXS) presents a challenge in the treatment of oxaliplatin-sensitive malignancies. Objective To analyze patient characteristics of patients with OXS, skin test results, and desensitization outcomes to optimize management. Methods Over 5 years, 48 patients with OXS were referred to the allergy/immunology unit at Massachusetts General Hospital. Their clinical reaction patterns were analyzed. Immediate hypersensitivity skin testing was used for risk stratification, and drug desensitizations were performed by using 3 related continuous intravenous protocols that were chosen based on clinical history, skin test reactivity, and the patients' previous desensitization outcomes. Results OXS occurred in both sexes, with mostly gastrointestinal-related tumors. Hypersensitivity reaction (HSR) onset had occurred during any course of therapy (course nos. 1-28), with a median onset at course no. 8. HSR to oxaliplatin was similar to those observed with cisplatin and carboplatin, including cutaneous, cardiovascular, pulmonary, and gastrointestinal symptoms. However, neurologic symptoms, including tingling, and systemic symptoms, including fever and chills, occurred more often in patients with OXS. Unique to OXS, 2 patients developed drug-induced thrombocytopenia; 1 patients also developed drug-induced hemolytic anemia. Skin testing was positive for the majority of patients with OXS (27/46 [59%]) and correlated with a greater likelihood of developing an HSR during subsequent desensitizations. We safely performed 200 desensitizations in 48 patients with OXS. Conclusion OXS is common with much similarity to other platin agents but also have distinct differences in the onset of hypersensitivity, sex, tumor type, drug-induced hemolytic anemia, and drug-induced thrombocytopenia. Skin testing was helpful for risk stratification. All of the desensitizations were completed successfully. Oxaliplatin hypersensitivity (OXS) presents a challenge in the treatment of oxaliplatin-sensitive malignancies. To analyze patient characteristics of patients with OXS, skin test results, and desensitization outcomes to optimize management. Over 5 years, 48 patients with OXS were referred to the allergy/immunology unit at Massachusetts General Hospital. Their clinical reaction patterns were analyzed. Immediate hypersensitivity skin testing was used for risk stratification, and drug desensitizations were performed by using 3 related continuous intravenous protocols that were chosen based on clinical history, skin test reactivity, and the patients' previous desensitization outcomes. OXS occurred in both sexes, with mostly gastrointestinal-related tumors. Hypersensitivity reaction (HSR) onset had occurred during any course of therapy (course nos. 1-28), with a median onset at course no. 8. HSR to oxaliplatin was similar to those observed with cisplatin and carboplatin, including cutaneous, cardiovascular, pulmonary, and gastrointestinal symptoms. However, neurologic symptoms, including tingling, and systemic symptoms, including fever and chills, occurred more often in patients with OXS. Unique to OXS, 2 patients developed drug-induced thrombocytopenia; 1 patients also developed drug-induced hemolytic anemia. Skin testing was positive for the majority of patients with OXS (27/46 [59%]) and correlated with a greater likelihood of developing an HSR during subsequent desensitizations. We safely performed 200 desensitizations in 48 patients with OXS. OXS is common with much similarity to other platin agents but also have distinct differences in the onset of hypersensitivity, sex, tumor type, drug-induced hemolytic anemia, and drug-induced thrombocytopenia. Skin testing was helpful for risk stratification. All of the desensitizations were completed successfully." @default.
• W1975525509 created "2016-06-24" @default.
• W1975525509 creator A5009787636 @default.
• W1975525509 creator A5025717970 @default.
• W1975525509 creator A5038528775 @default.
• W1975525509 creator A5064814823 @default.
• W1975525509 creator A5088844480 @default.
• W1975525509 date "2014-01-01" @default.
• W1975525509 modified "2023-10-17" @default.
• W1975525509 title "Oxaliplatin Hypersensitivity: Evaluation, Implications of Skin Testing, and Desensitization" @default.
• W1975525509 cites W1884062425 @default.
• W1975525509 cites W1907795058 @default.
• W1975525509 cites W1965734869 @default.
• W1975525509 cites W1966551245 @default.
• W1975525509 cites W1966985559 @default.
• W1975525509 cites W1969367596 @default.
• W1975525509 cites W1978017914 @default.
• W1975525509 cites W2008385633 @default.
• W1975525509 cites W2013117769 @default.
• W1975525509 cites W2036177573 @default.
• W1975525509 cites W2044229251 @default.
• W1975525509 cites W2085816407 @default.
• W1975525509 cites W2086126432 @default.
• W1975525509 cites W2100030862 @default.
• W1975525509 cites W2108160031 @default.
• W1975525509 cites W2121368761 @default.
• W1975525509 cites W2130177169 @default.
• W1975525509 cites W2130578368 @default.
• W1975525509 cites W2131001008 @default.
• W1975525509 cites W2141679770 @default.
• W1975525509 cites W2145347666 @default.
• W1975525509 cites W2156183281 @default.
• W1975525509 cites W2161636334 @default.
• W1975525509 cites W2162043213 @default.
• W1975525509 cites W2171232394 @default.
• W1975525509 doi "https://doi.org/10.1016/j.jaip.2013.08.011" @default.
• W1975525509 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24565767" @default.
• W1975525509 hasPublicationYear "2014" @default.
• W1975525509 type Work @default.
• W1975525509 sameAs 1975525509 @default.
• W1975525509 citedByCount "62" @default.
• W1975525509 countsByYear W19755255092014 @default.
• W1975525509 countsByYear W19755255092015 @default.
• W1975525509 countsByYear W19755255092016 @default.
• W1975525509 countsByYear W19755255092017 @default.
• W1975525509 countsByYear W19755255092018 @default.
• W1975525509 countsByYear W19755255092019 @default.
• W1975525509 countsByYear W19755255092020 @default.
• W1975525509 countsByYear W19755255092021 @default.
• W1975525509 countsByYear W19755255092022 @default.
• W1975525509 countsByYear W19755255092023 @default.
• W1975525509 crossrefType "journal-article" @default.
• W1975525509 hasAuthorship W1975525509A5009787636 @default.
• W1975525509 hasAuthorship W1975525509A5025717970 @default.
• W1975525509 hasAuthorship W1975525509A5038528775 @default.
• W1975525509 hasAuthorship W1975525509A5064814823 @default.
• W1975525509 hasAuthorship W1975525509A5088844480 @default.
• W1975525509 hasConcept C121608353 @default.
• W1975525509 hasConcept C126322002 @default.
• W1975525509 hasConcept C170493617 @default.
• W1975525509 hasConcept C2778248108 @default.
• W1975525509 hasConcept C2779779143 @default.
• W1975525509 hasConcept C2780962732 @default.
• W1975525509 hasConcept C526805850 @default.
• W1975525509 hasConcept C71924100 @default.
• W1975525509 hasConcept C90924648 @default.
• W1975525509 hasConceptScore W1975525509C121608353 @default.
• W1975525509 hasConceptScore W1975525509C126322002 @default.
• W1975525509 hasConceptScore W1975525509C170493617 @default.
• W1975525509 hasConceptScore W1975525509C2778248108 @default.
• W1975525509 hasConceptScore W1975525509C2779779143 @default.
• W1975525509 hasConceptScore W1975525509C2780962732 @default.
• W1975525509 hasConceptScore W1975525509C526805850 @default.
• W1975525509 hasConceptScore W1975525509C71924100 @default.
• W1975525509 hasConceptScore W1975525509C90924648 @default.
• W1975525509 hasIssue "1" @default.
• W1975525509 hasLocation W19755255091 @default.
• W1975525509 hasLocation W19755255092 @default.
• W1975525509 hasOpenAccess W1975525509 @default.
• W1975525509 hasPrimaryLocation W19755255091 @default.
• W1975525509 hasRelatedWork W1919657190 @default.
• W1975525509 hasRelatedWork W1965274356 @default.
• W1975525509 hasRelatedWork W2001816307 @default.
• W1975525509 hasRelatedWork W2028578103 @default.
• W1975525509 hasRelatedWork W2081398728 @default.
• W1975525509 hasRelatedWork W2097643886 @default.
• W1975525509 hasRelatedWork W2313795497 @default.
• W1975525509 hasRelatedWork W2462412038 @default.
• W1975525509 hasRelatedWork W2586527462 @default.
• W1975525509 hasRelatedWork W4362522697 @default.
• W1975525509 hasVolume "2" @default.
• W1975525509 isParatext "false" @default.
• W1975525509 isRetracted "false" @default.
• W1975525509 magId "1975525509" @default.
• W1975525509 workType "article" @default.